Log in with your email address username.


[Correspondence] Primary chemotherapy versus primary surgery for ovarian cancer

Sean Kehoe and colleagues (July 18, p 249)1 recently reported the results of the CHORUS trial and concluded that survival in women with advanced ovarian cancer receiving primary chemotherapy is non-inferior to primary debulking surgery.